Back to Agenda
Session 5: Track B: Responsible On-Boarding of Precision Medicine: Why Bytes and Spit Aren’t Enough
Session Chair(s)
Andrew Atkinson
Manager, Emerging Sciences Policy, Health Canada, Canada
Scientific advances are expanding the potential for personalized medicine to improve healthcare for Canadians. Equally, these developments could draw resources away from critical care in other healthcare sectors. In this session, the responsible introduction of personalized medicine will be explored including opportunities for cost savings, as well as mitigating the economic impacts of high cost treatments.
Speaker(s)
Health Technology Assessment for Reimbursement of Emerging Precision Medicine Technologies
Senior Scientist, The Hospital for Sick Children Research Institute, Canada
Personalized Healthcare: Unlocking the Data – Are We Ready?
Director, Evidence Generation, Medical Affairs, Hoffmann-La Roche Limited, Canada
Rated P/G: The Importance of Phenotype in a World of Genomic Data
Associate Professor of Medicine, Memorial University, Canada
Have an account?